Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1992 1
1993 3
1995 3
1996 1
1997 3
1998 1
1999 3
2000 1
2003 1
2004 1
2005 1
2007 1
2008 3
2009 1
2010 3
2011 5
2012 7
2013 8
2014 5
2015 5
2016 4
2017 3
2019 1
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: jakacki ri. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. Jakacki RI, et al. Neuro Oncol. 2016 Oct;18(10):1442-50. doi: 10.1093/neuonc/now038. Epub 2016 Mar 22. Neuro Oncol. 2016. PMID: 27006176 Free PMC article. Clinical Trial.
Ependymomas: development of immunotherapeutic strategies.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Expert Rev Neurother. 2013 Oct;13(10):1089-98. doi: 10.1586/14737175.2013.840420. Expert Rev Neurother. 2013. PMID: 24117271 Free PMC article. Review.
Peptide vaccine therapy for childhood gliomas.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Neurosurgery. 2013 Aug;60 Suppl 1:113-9. doi: 10.1227/01.neu.0000430769.33467.68. Neurosurgery. 2013. PMID: 23839362 Review. No abstract available.
Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience.
Bhatia A, Lee VK, Qian Y, Paldino MJ, Ceschin R, Hect J, Mountz JM, Sun D, Kohanbash G, Pollack IF, Jakacki RI, Boada F, Panigrahy A. Bhatia A, et al. Among authors: jakacki ri. Diagnostics (Basel). 2022 May 13;12(5):1223. doi: 10.3390/diagnostics12051223. Diagnostics (Basel). 2022. PMID: 35626378 Free PMC article.
Pseudoprogression of low-grade gliomas after radiotherapy.
Naftel RP, Pollack IF, Zuccoli G, Deutsch M, Jakacki RI. Naftel RP, et al. Among authors: jakacki ri. Pediatr Blood Cancer. 2015 Jan;62(1):35-9. doi: 10.1002/pbc.25179. Epub 2014 Sep 11. Pediatr Blood Cancer. 2015. PMID: 25213668
60 results